UK markets closed

CytomX Therapeutics, Inc. (CTMX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.4100+0.0200 (+1.44%)
At close: 04:00PM EST
1.4300 +0.02 (+1.42%)
After hours: 04:42PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.3900
Open1.3700
Bid1.3900 x 1100
Ask1.4100 x 800
Day's range1.3600 - 1.4300
52-week range1.0400 - 3.0200
Volume204,112
Avg. volume173,966
Market cap94.454M
Beta (5Y monthly)0.63
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

    - CX-904 (EGFRxCD3 T-cell engager) initial Phase 1 dose escalation data anticipated in the first half of 2024 - - CX-2051 (EpCAM-directed ADC) comprehensive preclinical profile presented at 14th Annual World ADC Conference; IND filing on track for year-end - - Updated CX-801 (conditionally activated interferon alpha-2b) preclinical data presented at SITC 2023; IND filing for CX-801 also on track for year-end - - Management to hold conference call today at 5 p.m. EDT / 2 p.m. PDT - SOUTH SAN FRAN

  • GlobeNewswire

    CytomX Therapeutics to Present at Upcoming November Investor Conferences

    SOUTH SAN FRANCISCO, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that management will participate in the following investor conferences in November. BMO Biopharma Spotlight Series: Oncology Day Date: Wednesday, November 8, 2023 Fireside Chat: 1:30 p.m. ET Location: Virtual Jefferies London Healthcare Conference Date: Thursday, November 16, 2023 Fireside Chat: 2:00 p.m. G

  • GlobeNewswire

    CytomX Therapeutics to Report Third Quarter 2023 Financial Results on November 7, 2023

    SOUTH SAN FRANCISCO, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that it will report third quarter financial results on Tuesday, November 7, 2023, after the close of U.S. markets. Following the announcement, the Company will host a conference call and webcast at 5:00 p.m. ET / 2:00 p.m. PT. Participants may access the live webcast of the conference call from the Events a